The Use of Biomarkers to Predict Specific Causes of Death in Patients with Atrial Fibrillation: Insights from the ARISTOTLE Trial.

Conclusions -Biomarkers were some of the strongest predictors of cause-specific death and may improve the ability to discriminate among patients' risks for different causes of death. These data suggest a potential role of biomarkers for identification of patients at risk for different causes of death in patients anticoagulated for AF. Clinical Trial Registration -URL: https://www.clinicaltrials.gov Unique Identifier: NCT00412984. PMID: 29871978 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29871978?dopt=Abstract

Source: Circulation - June 5, 2018 Category: Cardiology Authors: Sharma A, Hijazi Z, Andersson U, Al-Khatib SM, Lopes RD, Alexander JH, Held C, Hylek EM, Leonardi S, Hanna M, Ezekowitz JA, Siegbahn A, Granger CB, Wallentin L Tags: Circulation Source Type: research